Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

How we diagnose Myelodysplastic syndromes

13 Sept 2024

Abstract excerpt

The Myelodysplastic syndromes (MDS) are a heterogenous group of clonal bone marrow (BM) stem cell myeloid neoplasms, characterized by ineffective hematopoiesis that results in dysplasia in hematopoietic cells and peripheral cytopenias, especially anemia, and a propensity to leukemic transformation. The suspicion of MDS is raised by a typical but not specific clinical picture and routine laboratory findings, but...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Blood disorders and treatments
Share to Hematopoietic Stem Cell Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39346739
DOI: 10.3389/fonc.2024.1415101

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

How we diagnose Myelodysplastic syndromesPMID 39346739Read ↗

Diagnosis of myelodysplastic syndromes: the classic and the novelSemantic proximity Read ↗

Diagnostics and Prognostication of Myelodysplastic SyndromesSemantic proximity Read ↗

Myelodysplastic Syndrome: Diagnosis and ScreeningSemantic proximity Read ↗

The Use of Flow Cytometry in Myelodysplastic Syndromes: A ReviewSemantic proximity Read ↗

Diagnosis and classification of myelodysplastic syndromesSemantic proximity Read ↗

Myelodysplastic Syndromes: Updates and Nuances.Semantic proximity Read ↗

Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.Semantic proximity Read ↗

Advances in myelodysplastic/myeloproliferative neoplasms.Semantic proximity Read ↗

Genetic Aspects of Myelodysplastic/Myeloproliferative NeoplasmsSemantic proximity Read ↗

[Classification and clinical findings of myelodysplastic syndromes].Semantic proximity Read ↗

The myelodysplastic syndromes: diagnosis, molecular biology and risk assessment.Semantic proximity Read ↗

Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.